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Abstract Crude cell membranes in mammalian cells contain 
ADP-ribosyl cyclase, which converts NAD+ to cyclic ADP-
ribose. Acetylcholine either increases or inhibits this activity in 
NG108-15 neuronal cells and adrenal chromaffin cells in a 
muscarinic receptor subtype-specific manner. Activation or 
inhibition of the cyclase activity is mimicked by GTP and 
blocked by bacterial toxins. These findings suggest that hormone 
or neurotransmitter receptors utilize the direct signaling pathway 
to ADP-ribosyl cyclase via G proteins within cell membranes, 
analogous to the previously established transduction pathways to 
adenylyl cyclase and phospholipase Cp. 
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Cyclic adenosine diphosphate ribose (cADPR) [1] is synthe-
sized from (3-NAD+, an abundant intracellular substrate, by 
ADP-ribosyl cyclase in sea urchin eggs [2,3], ovotestis of Aply-
sia [4], canine spleen [5], pancreatic islet cells [6], murine [7] 
and human [8] T-lymphocytes, opossum kidney renal epithe-
lial cells [9], bovine adrenal chromaffin cells [10], rat cardiac 
muscle cells [11] and NG108-15 neuronal cells [12]. Pharma-
cological studies suggest that cADPR is an endogenous mod-
ulator of Ca2+-induced Ca2+ release [13,14] from ryanodine-
sensitive Ca2+ stores [15,16], where calmodulin is an activator 
[17]. However, the question whether or not cADPR mediates 
the intracellular action of conventional hormones and neuro-
transmitters in mammalian cells remains unsolved. For 
cADPR to be accepted as an intracellular second messenger 
downstream of such receptors, in addition to its pharmaco-
logical effects, several biochemical criteria should be fulfilled: 
(1) extracellular stimulation should activate (or inhibit) ADP-
ribosyl cyclase; (2) a transient decrease in substrate (NAD+) 
concentrations and an increase in the product (cADPR) 
should occur in association; and (3) quick elimination of 
cADPR by cADPR hydrolase. 
In sea urchin eggs, the precursor labeling protocol reveals 
that the formation of cADPR is enhanced by nitric oxide 
(NO) and cyclic GMP [3,18]. Since it is well known that 
NO and cyclic GMP are formed by stimulation of many kinds 
of agonists, it is speculated that the cADPR level is controlled 
by receptors through a complex cascade for the activation of 
ADP-ribosyl cyclase [19]. However, the exact signal pathway 
from hormone and neurotransmitter receptors to ADP-ribosyl 
cyclase in mammalian cells is still not clearly understood. 
The typical pathway in mammalian cells consists of signals 
from receptors involved in forming intracellular second mes-
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sengers, such as cyclic AMP or inositol-l,4,5-trisphosphate 
and diacylglycerol, being transduced to effector enzymes of 
adenylyl cyclase or phospholipase Cp via G proteins in the 
cell surface membrane [20]. Therefore, an analogy to this es-
tablished signaling pathway leads to an interesting hypothesis, 
namely that cADPR formation is regulated by ADP-ribosyl 
cyclase through the direct action of G proteins in the cell 
membrane. There are in fact two reports which support this 
hypothesis. 
Stimulation of muscarinic acetylcholine receptors 
(mAChRs) with acetylcholine or carbamoylcholine (CCh) ac-
tivates cADPR formation in bovine adrenal chromaffin cells 
[10] and NG108-15 neuroblastoma X glioma hybrid cells [12]. 
In both cases, the enzyme activity was found in crude mem-
brane fractions. Interestingly, activation of ADP-ribosyl cy-
clase by CCh was observed in membranes obtained from 
NG108-15 cells overexpressing ml or m3 mAChRs, while in-
hibition was mediated by endogenous m4 mAChRs and exog-
enous m2 mAChRs. These effects were mimicked by GTP in 
NG108-15 cells. The CCh-induced activation was inhibited by 
prior treatment of cells with cholera toxin, while the inhibition 
of ADP-ribosyl cyclase was sensitive to pertussis toxin. 
Although further validation is necessary to determine exactly 
which G proteins are involved in the stimulatory and inhib-
itory pathways to ADP-ribosyl cyclase, it can be hypothesized 
from these observations that the signal to ADP-ribosyl cy-
clase from mAChRs is mediated via G proteins, as shown 
in Fig. 1. 
This signaling seems to be comparable to that from other 
endogenous receptors expressed in NG108-15 cells, namely 
oiB2 adrenergic, 8 opioid, B2 bradykinin and P2u ATP recep-
tors, which have been shown to activate or inhibit adenylyl 
cyclase or to stimulate phospholipase Cp via G proteins 
[21,22] (Fig. 1). 
Another consequence of receptor-mediated regulation of 
ADP-ribosyl cyclase activity may be that the augmented or 
reduced cADPR may interact on the type 2 ryanodine recep-
tors in conjunction with the augmented cytosolic Ca2+ result-
ing from Ca2+ influx through voltage-activated Ca2+ channels 
[23,24], and subsequently modulate intracellular Ca2+ concen-
trations. 
The membrane-bound form of mammalian ADP-ribosyl 
cyclase is CD38, a cell surface antigen [25,26], or BST-1 
[27]. CD38 contains multiple enzyme activities, and catalyzes 
the conversion of NAD+ into cADPR by cyclase activity 
[7,28], of cADPR into ADPR by hydrolase activity [28,29], 
and of NAD+ into ADPR directly by glycohydrolase activity 
[30,31]. This multifunctional catalytic domain of CD38 seems 
to be located in the extracellular N-terminal region [29,30,32]. 
Thus, this estimate of the membrane topology of ectoenzyme 
CD38 runs counter to our speculation that the catalytic site of 
ADP-ribosyl cyclase is in the cell interior. Therefore, a new 
question has arisen, whether CD38 cell surface antigen repre-
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Fig. 1. Scheme of signal transduction from receptors to ADP-ribosyl 
cyclase, adenylyl cyclase, and phospholipase C via G proteins to 
produce second messengers, cADPR, cyclic AMP (cAMP), inositol 
trisphosphate (InsP3) and diacylglycerol (DAG), in NG108-15 cells. 
sents the endogenous ADP-ribosyl cyclase in NG108-15 or in 
chromaffin cells. 
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